AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cboe Global Markets
CBOE
|
+$1.07B |
| 2 |
Applovin
APP
|
+$455M |
| 3 |
Broadcom
AVGO
|
+$450M |
| 4 |
AXON
Axon Enterprise
AXON
|
+$442M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$440M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$1.6B |
| 2 |
Walt Disney
DIS
|
+$795M |
| 3 |
Idexx Laboratories
IDXX
|
+$692M |
| 4 |
Zoetis
ZTS
|
+$640M |
| 5 |
Microsoft
MSFT
|
+$615M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.02% |
| 2 | Healthcare | 12.31% |
| 3 | Consumer Discretionary | 11.7% |
| 4 | Financials | 11.01% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Entrada Therapeutics
TRDA
$236M
| $221K | ﹤0.01% |
12,770
| – | – |
|
3002
Virgin Galactic
SPCE
$325M
| $220K | ﹤0.01% |
37,334
-20,760
| -36% | -$138K |
|
3003
Omega Flex
OFLX
$305M
| $220K | ﹤0.01% |
5,230
| – | – |
|
|
LENZ
3004
LENZ Therapeutics
LENZ
$179M
| $219K | ﹤0.01% |
7,586
-1,760
| -19% | -$53.6K |
|
|
SRTA
3005
Strata Critical Medical Inc
SRTA
$445M
| $219K | ﹤0.01% |
51,470
-8,600
| -14% | -$32.7K |
|
3006
Astronics
ATRO
$3.47B
| $219K | ﹤0.01% |
16,440
-12,972
| -44% | -$191K |
|
3007
Invesco KBW Bank ETF
KBWB
$6.88B
| $218K | ﹤0.01% |
+3,335
| New | +$218K |
|
3008
Pure Cycle
PCYO
$260M
| $218K | ﹤0.01% |
17,160
-460
| -3% | -$5.62K |
|
|
LRGG
3009
Nomura Focused Large Growth ETF
LRGG
$306M
| $217K | ﹤0.01% |
+7,875
| New | +$218K |
|
|
AFCG
3010
AFC Gamma
AFCG
$60.9M
| $213K | ﹤0.01% |
25,620
| – | – |
|
3011
CVRx
CVRX
$129M
| $212K | ﹤0.01% |
16,760
-3,910
| -19% | -$48.2K |
|
3012
Bowman Consulting
BWMN
$459M
| $211K | ﹤0.01% |
8,460
| – | – |
|
3013
Allient
ALNT
$1.47B
| $211K | ﹤0.01% |
+8,680
| New | +$191K |
|
|
PDS
3014
Precision Drilling
PDS
$1.04B
| $211K | ﹤0.01% |
3,449
| – | – |
|
3015
Biglari Holdings Class B
BH
$1.17B
| $209K | ﹤0.01% |
+821
| New | +$165K |
|
3016
Voyager Therapeutics
VYGR
$187M
| $208K | ﹤0.01% |
36,750
| – | – |
|
3017
Quantum-Si Incorporated
QSI
$171M
| $205K | ﹤0.01% |
76,080
| – | – |
|
3018
Greene County Bancorp
GCBC
$569M
| $204K | ﹤0.01% |
7,370
| – | – |
|
|
BBBY
3019
Bed Bath & Beyond
BBBY
$512M
| $203K | ﹤0.01% |
45,210
| – | – |
|
3020
Nkarta
NKTX
$162M
| $201K | ﹤0.01% |
80,690
| – | – |
|
3021
Tango Therapeutics
TNGX
$4.35B
| $201K | ﹤0.01% |
64,940
| – | – |
|
3022
Sony
SONY
$131B
| $200K | ﹤0.01% |
+9,473
| New | +$185K |
|
|
MODV
3023
DELISTED
ModivCare
MODV
| $199K | ﹤0.01% |
16,803
| – | – |
|
3024
Alta Equipment Group
ALTG
$208M
| $196K | ﹤0.01% |
29,970
-3,340
| -10% | -$23.3K |
|
3025
Aura Biosciences
AURA
$741M
| $196K | ﹤0.01% |
23,820
| – | – |
|
Similar funds
AllianceBernstein's Q4 2024 Portfolio in Review
As of Q4 2024, AllianceBernstein held 3,298 positions worth $295B, down 1% from $298B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 4.4%. AllianceBernstein opened 67 new positions and exited 77, leaving the 3,298-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AllianceBernstein's largest Q4 2024 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,000,000 shares worth $157M.
- AllianceBernstein added most to Cboe Global Markets in Q4 2024, an estimated $1.07B increase.
- AllianceBernstein's biggest Q4 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $1.6B.
- AllianceBernstein fully exited iShares US Treasury Bond ETF in Q4 2024, selling an estimated $176M.
- AllianceBernstein's ten largest holdings make up 30% of its $295B portfolio in Q4 2024.
- AllianceBernstein opened 67 new positions and closed 77 in Q4 2024.
- AllianceBernstein's portfolio value fell 1% quarter-over-quarter to $295B.
Based on AllianceBernstein's 13F filing for Q4 2024, filed 12 Feb 2025.